PRESIDENT
Antonio Gasbarrini
Iscrizione
Per l’evento sono stati assegnati
n. 7 crediti formativi E.C.M.
ID evento: 6364 – 381648
L’evento è stato accreditato per le figure di:
Medico Chirurgo, Dietista, Farmacista, Infermiere
SCIENTIFIC COORDINATORS
Franco Scaldaferri
Loris Riccardo Lopetuso
SCIENTIFIC COMMITTEE
Alessandro Armuzzi
Giovanni Cammarota
Fabio Cominelli
Theresa Pizzarro
Maurizio Sanguinetti
Severine Vermeire
PROGRAM
08:30 – 09:00 Welcome coffee Participants Registration
Workshop: MICROBIOTA, FMT IN IBD – THE ROME MEETING
Chairs: Franco Scaldaferri, Loris Riccardo Lopetuso
09:00 – 09:15 Greetings and introduction to the day
Antonio Gasbarrini, Maurizio Sanguinetti
09:15 – 09:30 Gut Microbiota: impact on intestinal diseases and beyond
Herbert Tilg
09:30 – 09:45 Role of microbiota in human and experimental models of IBD
Theresa T. Pizarro
SESSION I: RESULTS OF THE FIRST CONSENSUS ON FMT IN IBD
Chairs: Severine Vermeire, Alessandro Armuzzi, Fabio Cominelli
10:00 – 10:15 Rationale for Microbiota modulation and FMT in IBD
Valentina Petito
10:15 – 10.30 Donor selection, bio-banking and population study
Sara Deleu
10:30 – 10:45 FMT trials in IBD: what have we learned?
Loris Riccardo Lopetuso
10:45 – 11:00 Future perspectives
Lihi Godny
11:00 – 11:15 DISCUSSION
11:15 – 11:30 COFFEE BREAK
SESSION II: BUILDING EVIDENCE FOR FMT IN IBD: from trial to clinical practice
Chairs: Luca Masucci, Giovanni Cammarota, Flavio Caprioli
11.30 – 11.45 What is missing from a methodology perspective?
Daniele Piovani
11:45 – 12:00 Patient profiling: UC
Alessandro Armuzzi
12:00 – 12:15 Patient profiling: pouchitis
Iris Dotan
12:15 – 12:30 Microbiota profilling
Sudarshan Paramsothy
12:30 – 12:45 Donor-microbiota matching?
Gianluca Ianiro
12:45 – 13:00 How to design future trials with FMT in IBD?
Severine Vermeire, Jeroen Raes
13:00 – 13:30 DISCUSSION
13:00 – 14:30 Lunch
SESSION III: BUILDING EVIDENCES ON PRE-PROBIOTICS USE IN IBD
Chairs: Stefania Vetrano, Gionata Fiorino, Daniela Pugliese
14:30 – 14:45 Probiotic in IBD: where do we stand
Paolo Gionchetti
14:45 – 15:00 Butyric acid and other compounds: state of the art
Sara Deleu
15:00 – 15:15 Prebiotic and diet in IBD
Davide Ribaldone
15:15 – 15:30 New and emerging pre/pro/post-biotic: future in IBD?
Federica Facciotti
15:30 – 16:00 Guidelines on probiotic use in IBD: what is missing
Daniele Piovani
16:00 – 16:15 DISCUSSION
16:15 -16:30 Coffee break
SESSION IV EXPLORATORY SESSION: Immune modulatory drugs and microbiota
Chairs: Theresa T. Pizarro, Lorenza Putignani, Lucrezia Laterza
16:30 – 16:45 Interactions between innate immunity and gut microbiota in chronic intestinal inflammation
Fabio Cominelli
16:45 – 17:00 Microbial and metabolomic predictors of response to anti TNF in patients with IBD
Daniela Pugliese
17:00 – 17:15 Microbial and metabolomic predictors of response to anti IL-23 and Jak pathway in IBD
Massimo Fantini
17:15 – 17:30 Microbial and metabolomic predictors of response to anti integrins/leukocyte trafficking in IBD
Flavio Caprioli
17:30 – 17:45 New horizons from clinical trials: emerging microbiota-targeted therapies in IBD
Gionata Fiorino
17.45 – 18.15 DISCUSSION
18:15 – 18:30 Closing remarks and CME Test
